PubMedCrossRef 28. Kariuki S, Gilks CF, Kimari J, Muyodi J, Waiyaki P, Hart CA: Plasmid diversity of multi-drug-resistant Escherichia coli isolated from children with diarrhoea in a poultry-farming area in Kenya. Ann Trop Med Parasitol 1997, 91:87–94.PubMedCrossRef
29. Miro E, Navarro F, Mirelis B, Sabate M, Rivera A, Coll P, Prats G: Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant beta-lactamases at a University Hospital in Barcelona, Spain, over a 3-year period. Antimicrob Agents Chemother 2002, 46:3991–3994.PubMedCrossRef 30. Perez-Moreno MO, Perez-Moreno M, Carulla M, Rubio C, Jardi AM, Zaragoza J: Mechanisms of reduced susceptibility to amoxycillin-clavulanic acid in Escherichia coli strains from the health region of Tortosa (Catalonia, Spain). Clin Microbiol Infect www.selleckchem.com/products/AG-014699.html 2004, 10:234–241.PubMedCrossRef 31. Mendonca N, Leitao J, Manageiro V, Ferreira E, Canica M: Spread of extended-spectrum beta-lactamase CTX-M-producing
escherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrob buy IWR-1 Agents Chemother 2007, 51:1946–1955.PubMedCrossRef 32. Rodriguez-Bano J, Lopez-Cerero L, Navarro MD, de Diaz AP, Pascual A: Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother 2008, 62:1142–1149.PubMedCrossRef 33. Carattoli A: Animal reservoirs for extended spectrum beta-lactamase producers. Clin Microbiol Infect 2008,14(Suppl 1):117–123.PubMedCrossRef 34. Livermore DM, James D, Reacher M, Graham C, Nichols T, Stephens P, Johnson AP, George RC: Trends in fluoroquinolone (ciprofloxacin) resistance in enterobacteriaceae from bacteremias, England and Wales, 1990–1999. Emerg
Infect Dis 2002, 8:473–478.PubMedCrossRef 35. Hanson ND, Moland ES, Hong SG, Propst K, Novak DJ, Cavalieri SJ: Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 beta-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community. Antimicrob Agents HSP90 Chemother 2008, 52:3814–3816.PubMedCrossRef 36. Gangoue-Pieboji J, Bedenic B, Koulla-Shiro S, Randegger C, Adiogo D, Ngassam P, Ndumbe P, Hachler H: Extended-spectrum-beta-lactamase-producing Enterobacteriaceae in Yaounde, Cameroon. J Clin Microbiol 2005, 43:3273–3277.PubMedCrossRef 37. Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, Ayala J, Coque TM, Kern-Zdanowicz I, Luzzaro F, Poirel L, Woodford N: CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007, 59:165–174.PubMedCrossRef 38. Pitout JD, Thomson KS, Hanson ND, Ehrhardt AF, Moland ES, Sanders CC: beta-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. Antimicrob Agents Chemother 1998, 42:1350–1354.PubMed 39.